Skip to content

A study to dtermine the use of serum biomarkers and thermography to doagnose bacterial infectioms in early post operative orthopedics patients

IDENN-TT Interleukin-6, Alpha Defensin, Leucocyte Esterase, Neutrophil Elastase, Neutrophil gelatinase associated Lipocalin, and infrared Thermography Trial for diagnosis of early postoperative infections in orthopaedic trauma. - IDENN-TT

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/02/039996
Enrollment
400
Registered
2022-02-03
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M00-M99- Diseases of the musculoskeletal system and connective tissue

Interventions

None listed

Sponsors

Science and Engineering Research Board SERB
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Case :Adult ( > 18 years) 1.Should have undergone an orthopaedic trauma surgery (with or without orthopaedic implants) and should have developed clinical signs of surgical site infection, within three weeks (early in-fection) post-operatively. 2.Should have a positive microbial culture 3.Should be willing to participate in the study Controls: Adult post-operative orthopaedic trauma patients with negative wound cultures and no cli-nico-radiological signs/symptoms of infection will be included as controls.

Exclusion criteria

Exclusion criteria: Exclusion Criteria 1.Children ( 2.Infections beyond 3 weeks. 3.Culture negative patients 4.Acute flare up of chronic infections 5.Patients in renal, hepatic or cardiac failure. 6.Patients with congenital or acquired immunodeficient states. 7.Patient not willing to give consent / participate in the study

Design outcomes

Primary

MeasureTime frame
To develop a diagnostic tool for early detection of the surgical site infection with serological markers.Timepoint: 6-24 months

Secondary

MeasureTime frame
to develop a new tool to predict and detect SSI at the early stage and an appropriate early intervention can be taken to prevent the fulminant infection.Timepoint: 18-24 months

Countries

India

Contacts

Public ContactDr Prasoon Kumar

Post graduate Institute of Medical Education and Research, Chandigarh

drprasoonksingh@gmail.com9781002142

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026